DRAFT — internal review copy — not published, not hosted, not for public distribution
MSC&Exosome.Ed
Section 9 of 10 — Condition-specific literature

COPD (Chronic Obstructive Pulmonary Disease): Current Research

A reproducible, date-sorted summary of the 20 most recently PubMed-indexed studies on mesenchymal stem cell or exosome approaches to COPD.

Educational information only — not medical or legal advice. This page is for general public education about FDA regulation of regenerative medicine. It does not diagnose, treat, or recommend treatment for any condition, and it is not a substitute for consulting a licensed physician about a medical question or a licensed attorney about a legal question. See the full disclaimer.
This is a literature summary, not a treatment claim. Listing a study here does not mean any MSC or exosome product is FDA-approved, safe, or effective for this condition. As of this draft, FDA has not approved any exosome product for any indication, and has not approved MSC-derived exosome therapy for this condition. This page describes what has been published in the peer-reviewed and preprint literature — it is not medical advice and is not a recommendation to pursue any specific treatment. Consult a licensed physician about any medical decision.
Search methodology. Studies were retrieved directly from the National Library of Medicine's PubMed database via the NCBI E-utilities API, using a combined search for mesenchymal stem cell OR exosome terms and the condition-specific terms below, sorted to surface the most recently indexed results. This is a mechanical, reproducible search — it is not a hand-curated "best evidence" list, and it was not filtered for study type or species (human vs. animal/preclinical); it includes randomized controlled trials, case reports, preclinical/animal studies, mechanistic laboratory studies, and narrative/systematic reviews. As a second pass, this list was manually screened for on-topic relevance to the condition named in the page title (removing results that matched the search terms technically but addressed a different anatomical site, an unrelated technology, or were not peer-reviewed), with each removed result backfilled by the next genuinely on-topic result from the same recency-sorted search. A reviewer should still independently assess study quality and peer-review status before citing any individual study as support for a specific claim.

Search terms used

(mesenchymal stem cell OR exosome) AND COPD — PubMed, sorted for recency, retrieved 2026/08/07 through 2026/01/05, 20 results of approximately 421 total matches for this search string.

Relevance cleanup applied. One non-peer-reviewed preprint (bioRxiv, PMID 41993529) and one unrelated biosensor-technology result that appeared to be a search false-positive (PMID 42041411) were removed and backfilled with the next genuinely on-topic, peer-reviewed results from the same recency-sorted search. A few remaining items are broad lung-disease or clinical-guideline reviews not specific to MSC/exosome therapy — these are left in as reasonably on-topic but should still be individually screened before citation.

20 most recent PubMed-indexed results

  1. Fibroblast Growth Factor Signaling in Lung Diseases: From Biological Roles to Therapeutic Delivery Strategies.
    Lee SB et al. — International journal of stem cells — 2026/08/07 — PMID: 42563572 · DOI: 10.15283/ijsc26054
  2. Cigarette Smoke-Exposed Alveolar Epithelial Cell-Derived Exosomes Exacerbate Skeletal Muscle Dysfunction Through HDAC2 Signalling.
    Li C et al. — Journal of cachexia, sarcopenia and muscle — 2026/08/01 — PMID: 42473083 · DOI: 10.1002/jcsm.70349
  3. Macrophage polarization as a therapeutic target in lung diseases: From pathogenesis to precision intervention.
    Kuang H et al. — International immunopharmacology — 2026/07/01 — PMID: 41999690 · DOI: 10.1016/j.intimp.2026.116660
  4. UC-MSCs prevent cigarette smoke-induced early cellular senescence like phenotype in bronchial epithelial cells via the SIRT1/PGC-1α pathway.
    Zhao L et al. — Scientific reports — 2026/06/30 — PMID: 42373880 · DOI: 10.1038/s41598-026-60236-z
  5. Exosomal miR-181d-5p derived from distal airway stem cells inhibit apoptosis of pulmonary vascular endothelial cells in COPD mice by targeting PDAP1.
    Song Q et al. — Stem cell research & therapy — 2026/06/25 — PMID: 42351225 · DOI: 10.1186/s13287-026-05118-x
  6. Extracellular vesicle cargo from lipofibroblasts mitigates chronic obstructive pulmonary disease by alveolar type 2 cell restoration.
    Fujimoto S et al. — American journal of respiratory and critical care medicine — 2026/06/01 — PMID: 41738201 · DOI: 10.1093/ajrccm/aamag025
  7. Regenerative therapeutics for chronic obstructive pulmonary disease.
    van der Koog L et al. — Pharmacological reviews — 2026/05/01 — PMID: 41856010 · DOI: 10.1016/j.pharmr.2026.100124
  8. Unlocking Alveolar Regeneration: AT2 Stem Cells, Signaling Networks, and Therapeutic Frontiers.
    Zhang Y et al. — Stem cell reviews and reports — 2026/05/01 — PMID: 41712129 · DOI: 10.1007/s12015-026-11086-9
  9. Macrophage exosomal ADAM10 mediates alveolar epithelial apoptosis induced by wood smoke PM(2.5).
    Zhan N et al. — Cell biology and toxicology — 2026/03/29 — PMID: 41904743 · DOI: 10.1007/s10565-026-10179-y
  10. Exosomal miR-2110 from PM2.5-Exposed Lung Epithelial Cells Targets SRSF1 to Promote M1 Macrophage Polarization and Inflammatory Responses in COPD.
    Miao Y et al. — International journal of chronic obstructive pulmonary disease — 2026/03/24 — PMID: 41909479 · DOI: 10.2147/COPD.S584536
  11. Ampicillin-Loaded Fenugreek-Derived Exosomes Treat COPD via Anti-Inflammatory, Antibacterial and Anti-Fibrotic Effects.
    Aierken H et al. — International journal of nanomedicine — 2026/03/19 — PMID: 41878130 · DOI: 10.2147/IJN.S578352
  12. Organoid-guided evidence that umbilical cord MSC-derived extracellular vesicles restore alveolar repair in cigarette smoke-induced lung injury.
    Che Shaffi S et al. — Frontiers in cell and developmental biology — 2026/03/17 — PMID: 41924092 · DOI: 10.3389/fcell.2026.1710021
  13. Ironing out COPD: ferroptosis-driven immune dysregulation, metabolic rewiring, and precision therapeutic opportunities.
    Ni FX et al. — Frontiers in immunology — 2026/02/27 — PMID: 41836443 · DOI: 10.3389/fimmu.2026.1630969
  14. Bronchial epithelial-derived exosomal SLC6A14 promotes airway inflammation and mucus hypersecretion via the ZFP36L1/IL-8 axis.
    Xiao Y et al. — Functional & integrative genomics — 2026/02/23 — PMID: 41724861 · DOI: 10.1007/s10142-026-01835-x
  15. BMSCs exosomes regulate pulmonary microvascular endothelial apoptosis via circRNA_43350/miR-342-5p in COPD.
    Zeng Y et al. — Scientific reports — 2026/02/10 — PMID: 41667834 · DOI: 10.1038/s41598-026-39678-y
  16. Piezo1 regulates remodeling of skin-derived extracellular matrix by embedded umbilical cord mesenchymal stem cells in a stiffness-dependent fashion.
    Zhao F et al. — Materials today. Bio — 2026/01/31 — PMID: 41696151 · DOI: 10.1016/j.mtbio.2026.102883
  17. A case report on nebulized human umbilical cord mesenchymal stem cell-derived exosome therapy for asthma and chronic obstructive pulmonary disease: A preliminary clinical evaluation.
    Yusof B et al. — SAGE open medical case reports — 2026/01/27 — PMID: 41625138 · DOI: 10.1177/2050313X251386547
  18. Optimizing COPD Care in Belgium: A Multidisciplinary Expert Consensus on Cardiopulmonary Risk Management.
    Michotte N et al. — International journal of chronic obstructive pulmonary disease — 2026/01/13 — PMID: 41939929 · DOI: 10.2147/COPD.S578651
  19. Cigarette smoke exposure triggers dendritic cell-derived exosome-mediated Th17 and Treg polarization through an autophagy- and necroptosis-associated SIRT1-dependent mechanism in vitro.
    Luo D et al. — Frontiers in immunology — 2026/01/06 — PMID: 41567193 · DOI: 10.3389/fimmu.2025.1715736
  20. Therapeutic effects and potential targets of UC-MSC-Exo in a mouse model of COPD.
    Zhou Y et al. — Scientific reports — 2026/01/05 — PMID: 41490942 · DOI: 10.1038/s41598-025-34896-2

Sources cited in this section

  1. PubMed E-utilities esearch query (COPD)
  2. Individual PMID links above each resolve to the study's PubMed record at pubmed.ncbi.nlm.nih.gov.